O’Melveny has advised Samsung Biologics. Samsung Biologics has signed a definitive agreement to acquire 100% of Human Genome Sciences from GSK for a total purchase price...
Samsung Biologics Acquires US-Based Human Genome Sciences Facility from GSK for $280 Million
Blackstone Products’ Business Combination with Weber
O’Melveny advised Blackstone Products on the deal. Weber LLC and Blackstone Products announced the completion of their business combination following the receipt of all regulatory approvals....